+ Importance of specific knowledge
- MRTs, within their scope of practice, administer or assist with the administration of various pharmacologic agents.
- MRTs should be familiar with and adhere to the specific policies and procedures at their institution with regard to administration of pharmacologic agents
- MRTs must have the appropriate authority at their institution to administer pharmacologic agents used in nuclear medicine
- An MRT should not administer a pharmacologic agent if he/she does not have knowledge, skills and judgement to respond to potential adverse reactions.1
- In order to safely administer pharmacologic agents, MRTs must be educated in and understand the following:2
- Physiologic effect of the medication
- Indications and contraindications
- Dose calculation
- Method of administration
- Possible adverse reactions and the means of responding to them
- Requirements for monitoring prior to, during and following the administration of an agent
- Need for medical supervision/physician presence with a given agent
+ Reference information on individual agents
- A departmental reference describing the information relevant to MRTs regarding individual agents (as described in Tab 1) is maintained.3
- Current information on pharmacologic agents from authoritative sources (e.g., Compendium of Pharmaceuticals and Specialities from Canada, US Pharmacopeia) are used to build this resource
- The departmental reference is reviewed on a regular a basis to ensure the currency of its information.
- Canadian Association of Medical Radiation Technologists. Code of Ethics. Available at: http://www.camrt.ca/abouttheprofession/codeofethics. Accessed March 20, 2013.
- Canadian Association of Medical Radiation Technologists. Nuclear Medicine Competency Profile. Revised January 2011. Available at: http://www.camrt.ca/certification/canadian/competencyprofiles/NM%20Comp%20Prof%202006.pdf. Accessed March 20, 2013.
- European Association of Nuclear Medicine. The Radiopharmacy. A Technologist's Guide. Available at: http://www.eanm.org/publications/tech_guidelines/docs/tech_radiopharmacy.pdf. Accessed March 20, 2013.